Life Science Company News

Reset
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain

Read more ››
By: GlobeNewswire - 03 Oct 2024
Related companies:  Ion Beam Applications S.A. (IBA)

CNN's 'Tomorrow Transformed' explores how the future of healthcare is connecting lives

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024
Related companies:  Flagship Pioneering

Caliway Successfully Lists on Taipei Exchange Following IPO

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024

New data indicates use of 3D specimen tomosynthesis can improve breast cancer surgical outcomes

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024

Kanazawa University research: Shedding light on how tissues grow with sharply defined structures

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 03 Oct 2024
Related companies:  OncoCyte Corporation

Oncocyte Signs Leading Transplant Centers in US and Germany

Read more ››
By: GlobeNewswire - 03 Oct 2024
Related companies:  OncoCyte Corporation

Now Scheduling Admissions: South Coast Behavioral Health, Oklahoma City

Read more ››
By: PR Newswire Association LLC. - 03 Oct 2024

ALPHA PRO TECH, LTD. ANNOUNCES $1 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM FOR IMMEDIATE RELEASE

Read more ››
By: GlobeNewswire - 02 Oct 2024

Cytokinetics to Host Investor & Analyst Day on October 16, 2024

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Cytokinetics, Inc.

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Fate Therapeutics, Inc.

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Processa Pharmaceuticals Inc.

Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Venus Concept Inc.

Range Impact Announces Sale of Cannabinoid Drug Development Business

Read more ››
By: GlobeNewswire - 02 Oct 2024

Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Kineta, Inc.

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Codexis, Inc.

Certara Completes Acquisition of Chemaxon

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Certara USA, Inc. | Certara Australia | Certara

Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Globus Medical Inc.

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Xilio Therapeutics, Inc.
Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »